1. Home
  2. AIRE vs RNXT Comparison

AIRE vs RNXT Comparison

Compare AIRE & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

HOLD

Current Price

$2.14

Market Cap

39.9M

Sector

N/A

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.82

Market Cap

37.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRE
RNXT
Founded
2021
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.9M
37.0M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
AIRE
RNXT
Price
$2.14
$0.82
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$1.30
$8.25
AVG Volume (30 Days)
1.2M
284.6K
Earning Date
04-28-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
60.34
20.00
EPS
N/A
N/A
Revenue
$4,518,498.00
$1,123,000.00
Revenue This Year
$129.06
$194.66
Revenue Next Year
$83.72
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
376.42
2511.63
52 Week Low
$0.14
$0.70
52 Week High
$3.98
$1.45

Technical Indicators

Market Signals
Indicator
AIRE
RNXT
Relative Strength Index (RSI) 61.12 37.44
Support Level $0.35 $0.81
Resistance Level $3.98 $1.07
Average True Range (ATR) 0.33 0.05
MACD -0.02 -0.00
Stochastic Oscillator 51.85 11.42

Price Performance

Historical Comparison
AIRE
RNXT

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are Homebuying Services and the Technology Services segment.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: